BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) announced that Robert A. Ingram was elected to the Company’s Board of Directors. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) belongs to Healthcare sector. Its weekly performance is -29.59%. On last trading day company shares ended up $10.90. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) distance from 50-day simple moving average (SMA50) is -24.43%.
Athersys, Inc. (NASDAQ:ATHX) reported total revenues were $0.2 million compared to $0.4 million in the comparable period in 2014, reflecting a decrease in grant revenues. Grant revenues may fluctuate from period to period due to the timing of grant-related activities and the award and expiration of grants, while contract revenues will be driven by license, royalty and milestone payments from existing and new business collaborations. Athersys, Inc. (NASDAQ:ATHX) shares moved up 8.82% in last trading session and ended the day at $1.11. ATHX return on assets is -63.80%. Athersys, Inc. (NASDAQ:ATHX) quarterly performance is -15.27%.
Lexmark International, Inc. (NYSE:LXK) announced that its Board of Directors declared a quarterly cash dividend of $0.36 per share of Lexmark Class A Common Stock. The dividend is payable on Sept. 11, 2015, to shareholders of record as of the close of business on Aug. 28, 2015. On 07 August, Lexmark International Inc. (NYSE:LXK) shares fell -1.94% and was closed at $32.41. LXK EPS growth in last 5 year was -7.60%. Lexmark International Inc. (NYSE:LXK) year to date (YTD) performance is -20.17%.
Perfumania Holdings, Inc. (NASDAQ:PERF) ended the last trading day at $5.56. Company weekly volatility is calculated as 0.38% and price to cash ratio as 50.60. Perfumania Holdings, Inc. (NASDAQ:PERF) showed a weekly performance of 0.18%.
Pzena Investment Management (NYSE:PZN) was upgraded by Zacks from a “sell” rating to a “hold” rating in a note issued to investors on Thursday, MarketBeat.Com reports. Pzena Investment Management, Inc (NYSE:PZN) shares moved up 0.94% in last trading session and ended the day at $10.70. PZN return on assets is 8.30%. Pzena Investment Management, Inc (NYSE:PZN) quarterly performance is 15.55%.